Ligustrosidic acid

• CAT Number: I016771
• CAS Number: 96382-89-7
• Molecular Formula: C25H30O14
• Molecular Weight: 554.50
• Purity: ≥95%
• Synonyms: (2E)-2-[4-[2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl]-5-methoxycarbonyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-ylidene]acetic acid
• InChI: InChI=1S/C25H30O14/c1-35-23(34)16-11-37-24(39-25-22(33)21(32)20(31)17(10-26)38-25)15(8-18(28)29)14(16)9-19(30)36-7-6-12-2-4-13(27)5-3-12/h2-5,8,11,14,17,20-22,24-27,31-33H,6-7,9-10H2,1H3,(H,28,29)/b15-8+/t14?,17-,20-,21+,22-,24?,25+/m1/s1
• InChIKey: DJAAGTPILCOZIR-MSISIIAVSA-N
• SMILES: COC(=O)C1=COC(C(=CC(=O)O)C1CC(=O)OCCC2=CC=C(C=C2)O)OC3C(C(C(C(O3)CO)O)O)O

Ligustrosidic Acid(CAT: I016771) is a secoiridoid glycoside isolated from plants of the Olea and Ligustrum genera, traditionally used in herbal medicine. It exhibits antioxidant, anti-inflammatory, and hepatoprotective activities, making it of interest in natural product and pharmacological research. Studies suggest that Ligustrosidic Acid helps regulate oxidative stress and inflammatory pathways, offering potential benefits in liver protection, cardiovascular support, and metabolic balance. Additionally, it has been investigated for its immunomodulatory effects and protective roles in tissue injury models. Ligustrosidic Acid is a valuable compound for exploring therapeutic mechanisms in metabolic, inflammatory, and liver-related disease research.